guanethidine has been researched along with captopril in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Anderson, RJ; Reed, WG | 1 |
| Bennett, T; Gardiner, SM | 1 |
| Scapellato, L; Stornello, M | 1 |
| Chernow, B; Coleman, MD; Lake, CR; Zaloga, GP; Ziegler, MG | 1 |
| Haas, GJ; Rankin, GO | 1 |
| Moyer, JH | 1 |
| Creekmore, JS; DeForrest, JM; Ferrone, RA | 1 |
| Antonaccio, MJ; Ferrone, RA; Heran, CL | 1 |
| Chichorro, JG; Lorenzetti, BB; Zampronio, AR | 1 |
3 review(s) available for guanethidine and captopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Bases of pharmacological therapy of essential hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Antihypertensive Agents; Captopril; Clonidine; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Minoxidil; Monoamine Oxidase Inhibitors; Prazosin; Secologanin Tryptamine Alkaloids | 1980 |
Drug systems approach to hypertension.
Topics: Captopril; Clonidine; Drug Combinations; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Methyldopa; Patient Compliance; Prazosin; Proteinuria; Renin-Angiotensin System; Reserpine; Spironolactone | 1984 |
11 other study(ies) available for guanethidine and captopril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Current concepts in treatment of hypertensive urgencies.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Central Nervous System; Clonidine; Diuretics; Ganglia; Guanethidine; Humans; Hypertension; Labetalol; Minoxidil; Patient Compliance; Prazosin; Sympatholytics; Vasodilator Agents | 1986 |
Factors contributing to the maintenance of arterial blood pressure in adult rats treated neonatally with guanethidine.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Blood Pressure; Captopril; Epinephrine; Female; Guanethidine; Heart Rate; Infusions, Intravenous; Male; Pentolinium Tartrate; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin; Renin-Angiotensin System; Vasopressins | 1986 |
Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
Topics: Antihypertensive Agents; Captopril; Clonidine; Guanethidine; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Reserpine; Sympathetic Nervous System; Vasodilator Agents | 1984 |
Effects of captopril on the development of tolerance to guanethidine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Drug Tolerance; Guanethidine; Heart Rate; Hypertension; Hypertension, Renovascular; Kinetics; Male; Proline; Rats; Rats, Inbred Strains; Renin | 1984 |
Hypertension after ending captopril administration: pathogenesis in 2-kidney, 1-clip rat.
Topics: Animals; Body Water; Captopril; Guanethidine; Hemodynamics; Humans; Hypertension; Male; Proline; Rats; Rats, Inbred Strains; Renin; Sodium; Substance Withdrawal Syndrome | 1984 |
Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine in spontaneously hypertensive rats.
Topics: Animals; Blood Circulation; Blood Pressure; Captopril; Cardiac Output; Guanethidine; Heart Rate; Hemodynamics; Hypertension; Male; Proline; Rats; Regional Blood Flow; Time Factors; Vascular Resistance | 1980 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine | 2004 |